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mononuclear layer containing stem cells is a novel approach for regeneration of
liver cell which can be a therapeutic option for those patients.
Aims & Methods: To determine the outcome after intrasplenic or intrahepatic
injection of autologous bone marrow stem cells (ABMSC) transplantation in
patients with liver cell failure secondary to chronic hepatitis C infection. Sixty
chronic hepatitis C patients with liver cell failure were prospectively enrolled.
They were classified into 3 groups; group I: 20 patients underwent (ABMSC)
injected intrasplenic. Group Ia: 10 patients underwent (ABMSC) injected intras-
plenic after trans differentiation into hepatocytes with regular amount of growth
factor. Group Ib: 10 patients underwent (ABMSC) injected intrasplenic after
trans differentiation into hepatocytes with the double amount of growth
factor. Group II: consisted of 20 patients underwent (ABMSC) injected intra
hepatic (right portal branch). Group IIa: 10 patients underwent (ABMSC)
injected intrahepatic after trans differentiation into hepatocytes using regular
amount of growth factor. Group IIb: 10 patients underwent (ABMSC) injected
intrahepatic; after trans differentiation into hepatocytes with the double amount
of growth factor. Group III: (Control Group): consisted of 20 patients received
traditional supportive treatment for chronic liver cell failure and symptomatic
treatment of ascites and bleeding abnormalities. All groups of patients were
followed regularly for nine months clinically, biochemically and ultrasonogra-
phically. Fatigue was assessed by the modified fatigue impact scale questionnaire
before, during and at end of the study.
Results: Our study included 60 patients (78.33% males) with mean ageSD
(49.9 6 years). Patients who had ABMSC injection showed improvement in
clinical parameters as bleeding tendency, ascites, lower limb edema and hepatic
encephalopathy. There was statistically significant improvement in serum albu-
min level and prothrombin time in group I and group II in comparison group III.
There was also statistically significant improvement in Child-Turcotte-Pugh in
group I and group II in comparison group III at the third month and this was
maintained till the end of the study. Fatigue improved in all patients who had
ABMSC. There was improvement in serum albumin, ascites, lower limb edema,
bleeding tendency and physical activity. Also there was improvement in MELD
score and performance status.
Conclusion: Stem cell transplantation has a beneficial effect on synthetic func-
tions of the liver and possibly improves survival and quality of life of patients
with end stage liver disease. Autologous bone marrow transplantation is safe and
beneficial technique in treatment of in patients with liver cell failure secondary to
chronic hepatitis C infection.
Disclosure of Interest: All authors have declared no conflicts of interest.
P0665 PERIPHERAL BLOOD MONONUCLEAR CELL
TRANSPLANTATION STIMULATES HEPATOCYTES
PROLIFERATION IN PATIENTS WITH ALCOHOLIC LIVER
CIRRHOSIS
G.R. Burganova1, S.R. Abdulkhakov1, I. M. Gazizov2, A. A. Gumerova1, M.
A. Titova1, R. Deev3, A. P. Kiyasov1
1Department Of Morphology And General Pathology, Kazan Federal University,
Kazan/Russian Federation
2Department Of Normal Human Anatomy, Kazan State Medical University,
Kazan/Russian Federation
3Department Of Patological Anatomy With Course Of Forensic Medicine, Ryazan
State Medical University, Ryazan/Russian Federation
Contact E-mail Address: guzel.burganova@gmail.com
Introduction: It is well known that severe liver disease requires a liver transplan-
tation to be treated. But liver transplantation is not available in many countries.
An alternative treatment can be a transplantation of autologous bone marrow
derived cells which can stimulate liver regeneration. Proliferating cell nuclear
antigen (PCNA) shows nuclei of dividing cells and may be useful for calculating
proliferation index.
Aims & Methods: The aim of this study was to evaluate changes of proliferation
intensity of liver cells in patients with alcoholip liver cirrhosis after autologous
peripheral blood mononuclear cell (PBMC) transplantation. This uncontrolled
open-labeled clinical trial was approved by Ethical committee of Ministry of
Health of the Republic of Tatarstan, Russia. Eleven patients took part in the
study, they received granulocyte colony-stimulating factor injections for 5 days
for PBMC mobilization. On the 6th day PBMCs were collected and injected into
the celiac trunk. Liver biopsies were obtained three times from each person on
next time-points: before transplantation of PBMCs into the celiac trunk (initial),
three and twelve months after the procedure. Liver biopsy specimens were
embedded in paraffin and stained immunohistochemically with antibodies
against PCNA. The PCNA labeling index was calculated as the number of
PCNA-labeled nuclei for 1000 hepatocyte nuclei in each specimen and the results
were expressed as percentage ratios. Statistical analysis was done by Wilcoxon
signed-rank test using Statistica v.12 software. p value 50.05 was considered
significant.
Results:. Before the transplantation of PBMCs 28.3 18.3% of all the hepato-
cytes expressed PCNA without any topographic prevalence. Three months after
the transplantation the proportion of proliferating hepatocytes increased up to
36.7 24.8%. Twelve months after transplantation of PBMCs we found hepa-
tocytes proliferation to be 2 times higher than before the procedure. Proportion
of proliferating hepatocytes reached 50.2 17.0% (p¼ 0.04). Great increase in
hepatocytes proliferation intensity coincided with biochemical improvements of
serum bilirubin, ALT and alkaline phosphatase.
Conclusion: Our study showed that proposed treatment was safe and effective.
We can conclude that after transplantation of autologous PBMC s proliferation
of hepatocytes greatly contributes to the liver regeneration and improvement of
blood biochemical data in patients with alcoholic liver cirrhosis. However, effect
of our treatment is not constant and requires repeated PBMC transplantation.
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Introduction: The prevalence of non-alcoholic fatty liver disease (NAFLD) has
increased and several studies have shown that there is an association between
NAFLD and metabolic syndrome (MetS). The aim of this study was to deter-
mine how much impact the risk factors of metabolic syndrome has on ultrasono-
graphic fatty liver, especially NAFLD.
Aims & Methods: A total of 41,258 adults who underwent routine comprehensive
health evaluations, including abdominal ultrasonography, were selected. We cal-
culated the adjusted prevalence ratios (PRs) for components of MetS (high blood
pressure (BP), impaired fasting glucose, low high-density lipoprotein cholesterol
(HDL-C), and high triglycerides (TG) according to NAFLD.
Results: NAFLD was found in 13.8% of non-obese subjects and 52.3% of obese
subjects. NAFLD was associated with most components of MetS in both obese
and non-obese subjects. However, non-obese NAFLD patients had significantly
higher PRs for certain components of MetS than did obese patients, especially
among women. Body mass index, waist circumference, fasting blood glucose,
triglyceride, HDL-C and aspartate aminotransferase, alanine aminotransferase,
-glutamyl transpeptidase levels all affected NAFLD independently. The preva-
lence of metabolic syndrome was increased in mild (40.8%) and moderate
(57.8%) NAFLD groups. When odd ratio (95% CI) for NAFLD group was
compared to the contrast group, there was an increased risk of metabolic syn-
drome with odd ratio of 12.8 (95% CI, 9.1 17.0).
Conclusion: NAFLD and its severity has a close connection with MetS and also
with each risk factors of MetS. Therefore, assessment for concurrent MetS
among NAFLD patients is considered to be necessary.
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Introduction: Obesity is a global problem. Data from the South Asian region is
limited.
Aims & Methods: In a cohort follow-up study we investigated obesity among
urban, adult, Sri Lankans [selected by age-stratified random sampling from
Ragama-MOH area, Gampaha District; initial screening 2007 (aged 35–64
years); re-evaluation 2014 (aged 42–71 years)]. On both occasions structured
interview, anthropometry, liver ultrasound, biochemical and serological tests
were performed. Total body fat (TBF) and visceral fat percentage (VFP) were
assessed by impedance in 2014. General-obesity (GO) was BMI4 25 kg/m2.
Central-obesity (CO) was waist circumference (WC)4 90 cm males and
WC4 80 cm females. Non-alcoholic fatty liver disease (NAFLD) was diagnosed
on ultrasound criteria, safe alcohol consumption and absence of hepatitis B/C
markers. Multinomial logistic regression was fitted to assess associations.
Results: In 2007 (n¼ 2967), 614(20.7%) were overweight [51.9%-women],
1161(39.1%) had GO [65.9%-women] and 1584(53.4%) had CO [71%-women].
Females (p5 0.001), raised-TG (p5 0.001), low-HDL (p5 0.001), diabetes
(p5 0.001), hypertension (p5 0.001), NAFLD (p5 0.001), and low household
income (p5 0.001) were significantly associated with prevalent GO and CO
respectively. Additionally, increased-age (p¼ 0.05), low-educational level
(p5 0.001) and unhealthy eating (p5 0.001) were associated with prevalent
CO. Inadequate physical activity was not associated with either. 2137(72%)
attended follow-up in 2014. Of those who were initially non-obese who attended
follow-up, 189/1270(14.9%) [64% women] had developed GO (annual-incidence
2.13%) and 206/947(21.9%) [56.3% women] had developed CO (annual inci-
dence 3.12%) after 7 years. TBF and VFP significantly correlated with incident
GO and CO (p5 0.001). Females gender (OR-1.78, p5 0.001; 2.81, p5 0.001)
and NAFLD (OR-2.93, p5 0.001; OR-2.27, p5 0.001) independently predicted
incident GO and CO respectively.
Conclusion: The prevalence and incidence of GO and CO were high in this
cohort. Both incident GO and CO were associated with female gender and
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